A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Clinical trial NCT01770834 · COMPLETED
Trial details
- NCT number
- NCT01770834
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-18
- Primary completion
- 2017-01-25
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.